In this engaging discussion, Ivor Horn, a seasoned pediatrician and primary care innovator, teams up with Jeff Kaditz, CEO of Q.bio, to redefine the future of primary care. They delve into the need for a new patient-centered system, emphasizing innovative data collection including social determinants of health. Topics include improving patient access, utilizing telemedicine, and addressing biases in traditional healthcare data. Together, they envision a more effective, holistic approach to personalized care, enhancing health outcomes for all.

Join an enlightening discussion with Kristen Fortney, CEO of BioAge Labs, Jeff Kaditz, co-founder of Q.Bio, David Sinclair, co-director at Harvard's Glenn Center, and Michael Snyder, Stanford's Genetics Chair. They dive into groundbreaking advancements in longevity, highlighting the importance of early disease detection and genomics. Explore innovative tools targeting aging, like the elimination of senescent cells, and how tech is revolutionizing healthcare from reactive to proactive. Discover the societal shifts towards personalized health data ownership for improved aging outcomes.

Carlos Araya, CEO of Jungla, Jeff Kaditz, CEO of Q, and Gabe Otte, CEO of Freenome, dive into the evolving world of genomics. They discuss how our understanding of DNA has transformed since the Human Genome Project, revealing it as a dynamic system. The conversation highlights the necessity of combining genomic and phenotypic data for accuracy in medical diagnostics. They also tackle commercialization hurdles and the push for preventative care, emphasizing the potential of machine learning to reshape genomics in healthcare.